CD40LG and COVID-19: Interestingly, a study showed that IgM antibody levels for patients with moderate to severe COVID-19 were higher for the first 14 days after the onset of COVID-19 symptoms as compared to the levels for those with mild COVID-19 (Hu et al., 2020).